Contrary to prior data, this study shows that neither eosinophils nor STAT6-mediated IL-4/IL-13 signaling contribute ...
The Gene Therapy Centre will solidify Sidra Medicine’s position as a regional leader in advanced care, attracting families from across the GCC and the Middle East and North Africa region ...
Special rebroadcasts: Landon Gray on the future of AI; understanding gene therapy for young children
"Connections with Evan Dawson" brings you special rebroadcasts on 1/30/25. First, AI expert Landon Gray on the future of ...
Discover the importance of vision, genetic eye disorders, and RNA-based therapies for precision treatment in India and ...
The robust vendor analysis is designed to help clients improve their market position. This report provides a detailed analysis of several leading market vendors in Saudi Arabia, and includes ...
Top-line Phase 3 trial data show ambulatory boys with Duchenne continued with motor improvements two years after a single ...
The announcement was made at Arab Health 2025 where Sidra Medicine will highlight its international patient service programmes ...
Sidra Medicine, a member of Qatar Foundation, has established a gene therapy centre to treat rare genetic diseases such as ...
Sarepta Therapeutics (NASDAQ:SRPT), a biotechnology company specializing in precision genetic medicines for rare diseases with a market capitalization of $11.2 billion, stands at a critical juncture ...
In year two of the trial, Elevidys demonstrated statistically significant and clinically improvements across three key ...
The gene therapy delandistrogene moxeparvovec-rokl showed clinically meaningful benefits and disease stabilization at 2 years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback